Author:
Bakeer Mostafa,Touman AbdelfattahA,Fouda AhmedM
Reference16 articles.
1. Gandevia B Historical review of the use of parasympatholytic agents in the treatment of respiratory disorders. Postgrad Med J 1975; 51(7 suppl):13–20.
2. Rau JL The inhalation of drugs: advantages and problems. Respir Care 2005; 50:367–382.
3. Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, et al Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011; 105:930–938.
4. Virchow JC, Crompton GK, Dal Negro R, Pedersen S, Magnan A, Seidenberg J, Barnes PJ Importance of inhaler devices in the management of airway disease. Respir Med 2008; 102:10–19.
5. Kaplan A, Price D Matching inhaler devices with patients: the role of the primary care physician. Can Respir J 2018; 2018:9473051.